CPG
REGN icon

Cornerstone Planning Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Cornerstone Planning Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Sell
20
-15
-43% -$10.2K ﹤0.01% 807
2026
Q1 		$23.9K Buy
35
+13
+59% +$9.95K ﹤0.01% 620
2025
Q4 		$16.5K Sell
22
-126
-85% -$85.6K ﹤0.01% 634
2025
Q3 		$3.58K Buy
148
+134
+957% +$75.8K ﹤0.01% 1033
2025
Q2 		$7.98K Buy
14
+4
+40% +$2.23K ﹤0.01% 611
2025
Q1 		$5.88K Buy
10
+4
+67% +$2.75K ﹤0.01% 690
2024
Q4 		$4.11K Buy
6
+2
+50% +$1.68K ﹤0.01% 621
2024
Q3 		$3.71K Buy
4
+1
+33% +$1.11K ﹤0.01% 638
2024
Q2 		$3.21K Buy
3
+2
+200% +$1.94K ﹤0.01% 661
2024
Q1 		$957 Hold
1
– – ﹤0.01% 792
2023
Q4 		$878 Hold
1
– – ﹤0.01% 732
2023
Q3 		$823 Buy
+1
New +$786 ﹤0.01% 827

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Cornerstone Planning Group's REGN Position: Q2 2026 in Review

Cornerstone Planning Group reduced its Regeneron Pharmaceuticals (REGN) stake by 43% in Q2 2026, selling an estimated $10.2K and leaving 20 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #807.

Cornerstone Planning Group first reported a position in REGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $23.9K in Q1 2026. 789 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Cornerstone Planning Group held 20 shares of Regeneron Pharmaceuticals worth $13K as of Q2 2026.
  • Cornerstone Planning Group sold 15 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $10.2K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #807 holding.
  • Cornerstone Planning Group first reported a position in Regeneron Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Cornerstone Planning Group's Regeneron Pharmaceuticals position peaked at $23.9K in Q1 2026.
  • 789 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.